financetom
Business
financetom
/
Business
/
Market Chatter: Sam Bankman-Fried Parents Seek Trump Pardon for Son Convicted in Crypto Scam
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Sam Bankman-Fried Parents Seek Trump Pardon for Son Convicted in Crypto Scam
Jan 30, 2025 12:41 PM

03:19 PM EST, 01/30/2025 (MT Newswires) -- Sam Bankman-Fried's parents have been meeting with lawyers and others close to US President Donald Trump in a bid to secure a pardon for their son, sentenced to 25 years in federal prison for fraud related to the collapse of FTX crypto exchange, Bloomberg reported Thursday, citing a person familiar with the matter.

It was unclear whether the parents, Joseph Bankman and Barbara Fried, have reached out to the White House yet, according to the report. Bankman-Fried was convicted in July 2023 and sentenced last March on seven counts of fraud and conspiracy, stemming from the collapse of FTX and a related hedge fund, Alameda Research, in November 2022.

Bankman-Fried's attorneys did not immediately respond to a request for comments from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kimberly-Clark Shares Tumble After Missing Revenue Targets Despite Earnings Growth
Kimberly-Clark Shares Tumble After Missing Revenue Targets Despite Earnings Growth
Jul 23, 2024
Kimberly-Clark Corporation ( KMB ) shares are trading lower following mixed second-quarter earnings. Kimberly-Clark ( KMB ) reported quarterly adjusted earnings per share of $1.96 (+19%), beating the analyst consensus of $1.71. Quarterly revenues of $5.029 billion, missing the street view of $5.109 billion. Sales in the second quarter reflected a 2% decline from the previous year, influenced by a...
Novo Nordisk's Wegovy gets UK approval for lowering heart risks
Novo Nordisk's Wegovy gets UK approval for lowering heart risks
Jul 23, 2024
July 23 (Reuters) - Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight and obese adults suffering serious heart problems or strokes, the agency said on Tuesday. Approval from UK's Medicines and Healthcare products Regulatory Agency makes Wegovy the first GLP-1 weight-loss drug to be prescribed for prevention of...
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
Jul 23, 2024
On Tuesday, MAIA Biotechnology Inc ( MAIA ) announced treatment updates from its Phase 2 THIO-101 trial of THIO sequenced with Regeneron Pharmaceuticals Inc’s cemiplimab (Libtayo) for advanced non-small-cell-lung-cancer patients who failed two or more standard-of-care therapy regimens. The trial’s therapeutic regimen is cycled every three weeks, with THIO 180mg administered in 60mg incremental doses on days 1, 2 and...
--Norfolk Southern Keeps Quarterly Dividend at $1.35 Per Share, Payable Aug. 20 to Shareholders of Record Aug. 2
--Norfolk Southern Keeps Quarterly Dividend at $1.35 Per Share, Payable Aug. 20 to Shareholders of Record Aug. 2
Jul 23, 2024
10:42 AM EDT, 07/23/2024 (MT Newswires) -- Price: 226.75, Change: -1.28, Percent Change: -0.56 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved